{"transactions":[{"id":1289385,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":13158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"These shares were issued to Mr. Lucido pursuant to the Director Agreement. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares Common Stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.38."}],"balance_after":2511940,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289384,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":43860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.38."}],"balance_after":2498782,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289383,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-11-29","kind":"grant","planned":false,"acquired":true,"shares":55494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.31."}],"balance_after":2454922,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289382,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-10-31","kind":"grant","planned":false,"acquired":true,"shares":55556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.30."}],"balance_after":2399428,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289381,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-10-14","kind":"grant","planned":false,"acquired":true,"shares":1105218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido dated October 14, 2024 (the \"October 2024 Exchange Agreement\"). Pursuant to the October 2024 Exchange Agreement, Mr. Lucido agreed to the exchange the aggregate amount of $387,6700 of director's fees and loans to a subsidiary of the Company for 1,105,218 shares of Common Stock at a price of $0.36 per share based on the underlying value of the Common Stock at the date of issuance."}],"balance_after":2343872,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289380,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019 (the \"Director Agreement\"), by and between the Company and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares Common Stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.32."}],"balance_after":1238654,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289379,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":52085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.32."}],"balance_after":1223029,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289378,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-08-30","kind":"grant","planned":false,"acquired":true,"shares":55559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.30."}],"balance_after":1170944,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289377,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-07-31","kind":"grant","planned":false,"acquired":true,"shares":32092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.5193."}],"balance_after":1115385,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289376,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T16:19:44.000Z","date":"2024-04-24","kind":"other","planned":false,"acquired":true,"shares":460477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido dated April 24, 2024 (the \"April 2024 Exchange Agreement\"). Pursuant to the April 2024 Exchange Agreement, Mr. Lucido agreed to the exchange of a promissory note then outstanding in the amount of $446,426 and the accrued interest on such promissory note of $7,858 and director fees of $90,000 for 460,477 shares of the Company's common stock, par value $0.001 per share (the \"Common Stock\") at a price of $1.18 per share based on the underlying value of the Common Stock at the date of issuance."}],"balance_after":1083293,"source":{"system":"sec-edgar","filing":"0001477932-25-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000598/form4.xml","form_type":"4"}},{"id":1289372,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T13:50:18.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":13158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were issued to Ms. Felix pursuant to the Director Agreement. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of Common Stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.38."}],"balance_after":843578,"source":{"system":"sec-edgar","filing":"0001477932-25-000576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000576/form4.xml","form_type":"4"}},{"id":1289371,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T13:50:18.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares were issued to Ms. Felix pursuant to a Director Agreement (the \"Director Agreement\"), dated March 1, 2019, by and between the Company and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of Common Stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.32."}],"balance_after":830420,"source":{"system":"sec-edgar","filing":"0001477932-25-000576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000576/form4.xml","form_type":"4"}},{"id":1289370,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T13:50:18.000Z","date":"2024-07-02","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Ms. Felix pursuant to a Stock Grant Award Agreement (the \"Award Agreement\") by and between the Company and Ms. Felix, dated July 2, 2024. Pursuant to the Award Agreement, in recognition of Ms. Felix's services to the Company, and for assuming additional responsibilities, the Company issued 500,000 shares of Common Stock to Ms. Felix, representing an amount equal to $235,000, or $0.32 per share based on the closing price of the Common Stock on the date of issuance. These shares are subject to lock-up obligations for a period of 180 days following the date on which the Company's securities become listed for trading on a national securities exchange."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares are subject to lock-up obligations for a period of 180 days following the effective date of a registration statement of the Company filed under the Securities Act of 1933, as amended, pursuant to which the Company's securities become listed for trading on a national securities exchange or such longer period to facilitate compliance with FINRA Rule 2241 or any successor or similar rule or regulation."}],"balance_after":814795,"source":{"system":"sec-edgar","filing":"0001477932-25-000576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000576/form4.xml","form_type":"4"}},{"id":1289369,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2025-01-31T13:50:18.000Z","date":"2024-04-24","kind":"grant","planned":false,"acquired":true,"shares":224196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Felix pursuant to an Exchange Agreement (the \"April 2024 Exchange Agreement\") by and between BioCorRx Inc. (the \"Company\") and Ms. Felix dated April 24, 2024. Pursuant to the April 2024 Exchange Agreement, Ms. Felix agreed to the exchange of directors fees in the amount of $265,000 for 224,196 shares of the Company's common stock, par value $0.001 per share (the \"Common Stock\") at a price of $1.18 per share based on the underlying value of the Common Stock at the date of issuance."}],"balance_after":314795,"source":{"system":"sec-edgar","filing":"0001477932-25-000576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793225000576/form4.xml","form_type":"4"}},{"id":1456901,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-07-10T17:02:37.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":34016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49."}],"balance_after":622816,"source":{"system":"sec-edgar","filing":"0001477932-24-004156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224004156/form4.xml","form_type":"4"}},{"id":1456900,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-07-10T17:02:37.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":10204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock par value $0.001 per share (the \"Common Stock\") equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49."}],"balance_after":588800,"source":{"system":"sec-edgar","filing":"0001477932-24-004156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224004156/form4.xml","form_type":"4"}},{"id":1458267,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":17983,"kind":"person","name":"Ingargiola Luisa","position":1,"cik":"0001447277","reported_name":"Ingargiola Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2024-07-08T19:53:10.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":10204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49."}],"balance_after":64191,"source":{"system":"sec-edgar","filing":"0001477932-24-004105","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447277/000147793224004105/form4.xml","form_type":"4"}},{"id":1458266,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":17983,"kind":"person","name":"Ingargiola Luisa","position":1,"cik":"0001447277","reported_name":"Ingargiola Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2024-07-08T19:53:10.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90."}],"balance_after":53987,"source":{"system":"sec-edgar","filing":"0001477932-24-004105","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447277/000147793224004105/form4.xml","form_type":"4"}},{"id":1458264,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2024-07-08T19:47:16.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":10204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Felix pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49."}],"balance_after":90599,"source":{"system":"sec-edgar","filing":"0001477932-24-004103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224004103/form4.xml","form_type":"4"}},{"id":1495006,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-06-04T01:44:46.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":22831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.73."}],"balance_after":578596,"source":{"system":"sec-edgar","filing":"0001477932-24-003436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224003436/form4.xml","form_type":"4"}},{"id":1531905,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-05-02T00:17:27.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":21552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.77."}],"balance_after":555765,"source":{"system":"sec-edgar","filing":"0001477932-24-002476","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224002476/form4.xml","form_type":"4"}},{"id":1546600,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92183,"kind":"person","name":"GALLIGAN JOSEPH J","position":1,"cik":"0001198613","reported_name":"GALLIGAN JOSEPH J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2024-04-05T20:19:49.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90."}],"balance_after":237858,"source":{"system":"sec-edgar","filing":"0001477932-24-001895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001895/form4.xml","form_type":"4"}},{"id":1546599,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92183,"kind":"person","name":"GALLIGAN JOSEPH J","position":1,"cik":"0001198613","reported_name":"GALLIGAN JOSEPH J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2024-04-05T20:19:49.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81."}],"balance_after":232292,"source":{"system":"sec-edgar","filing":"0001477932-24-001895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001895/form4.xml","form_type":"4"}},{"id":1549350,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92265,"kind":"person","name":"Granier Brady James","position":1,"cik":"0001570636","reported_name":"Granier Brady James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-04-03T15:45:00.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":16698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 28, 2024, the issuer granted the reporting person an option that was 100% vested on issuance."}],"balance_after":16698,"derivative":{"exercise_price":0.9,"exercise_date":"2024-03-28","expiration_date":"2029-03-28","underlying":"Common Stock","underlying_shares":16698},"source":{"system":"sec-edgar","filing":"0001477932-24-001832","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001832/form4.xml","form_type":"4"}},{"id":1549352,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92266,"kind":"person","name":"Murthy Harsha","position":1,"cik":"0001962250","reported_name":"Murthy Harsha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2024-04-03T13:51:11.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Murthy pursuant to a Director Agreement, dated January 20, 2023, by and between BioCorRx Inc. and Mr. Murthy. As compensation for his services, Mr. Murthy shall be issued, upon the last day of each fiscal quarter, provided Mr. Murthy is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90."}],"balance_after":19719,"source":{"system":"sec-edgar","filing":"0001477932-24-001822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001822/form4.xml","form_type":"4"}},{"id":1549351,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92266,"kind":"person","name":"Murthy Harsha","position":1,"cik":"0001962250","reported_name":"Murthy Harsha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2024-04-03T13:51:11.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Murthy pursuant to a Director Agreement, dated January 20, 2023, by and between BioCorRx Inc. and Mr. Murthy. As compensation for his services, Mr. Murthy shall be issued, upon the last day of each fiscal quarter, provided Mr. Murthy is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81."}],"balance_after":14153,"source":{"system":"sec-edgar","filing":"0001477932-24-001822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001822/form4.xml","form_type":"4"}},{"id":1549349,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-04-03T13:00:43.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":18553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90."}],"balance_after":534213,"source":{"system":"sec-edgar","filing":"0001477932-24-001820","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001820/form4.xml","form_type":"4"}},{"id":1549348,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-04-03T13:00:43.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock par value $0.001 per share (the \"Common Stock\") equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90."}],"balance_after":515660,"source":{"system":"sec-edgar","filing":"0001477932-24-001820","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001820/form4.xml","form_type":"4"}},{"id":1549344,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2024-04-03T10:05:43.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Felix pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90."}],"balance_after":80395,"source":{"system":"sec-edgar","filing":"0001477932-24-001806","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001806/form4.xml","form_type":"4"}},{"id":1589004,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-03-08T00:42:39.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":16892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant to the Agreement. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares of Common Stock equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.98."}],"balance_after":510094,"source":{"system":"sec-edgar","filing":"0001477932-24-001093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001093/form4.xml","form_type":"4"}},{"id":1589003,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-03-08T00:42:39.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":18269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the \"Agreement\"), dated January 5, 2024, by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares of the Company's common stock, par value $0.001 per share (the \"Common Stock\"), equivalent to $16,666.66 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.80."}],"balance_after":493202,"source":{"system":"sec-edgar","filing":"0001477932-24-001093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224001093/form4.xml","form_type":"4"}},{"id":1677778,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-01-17T21:15:31.000Z","date":"2024-01-16","kind":"purchase","planned":false,"acquired":true,"shares":126,"price":0.7,"value":88.2,"ownership":{"direct":true},"balance_after":474933,"source":{"system":"sec-edgar","filing":"0001477932-24-000249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224000249/form4.xml","form_type":"4"}},{"id":1677777,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim President"}}],"security":"Common Stock, par value $0.001","published_at":"2024-01-17T21:15:31.000Z","date":"2024-01-12","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":0.7,"value":2100.0,"ownership":{"direct":true},"balance_after":474807,"source":{"system":"sec-edgar","filing":"0001477932-24-000249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224000249/form4.xml","form_type":"4"}},{"id":1687628,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2024-01-04T22:00:04.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Felix pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81."}],"balance_after":74829,"source":{"system":"sec-edgar","filing":"0001477932-24-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224000043/form4.xml","form_type":"4"}},{"id":1687627,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92265,"kind":"person","name":"Granier Brady James","position":1,"cik":"0001570636","reported_name":"Granier Brady James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2024-01-04T21:59:46.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":18519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2024, the issuer granted the reporting person an option that was 100% vested on issuance."}],"balance_after":18519,"derivative":{"exercise_price":0.81,"exercise_date":"2024-01-02","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":18519},"source":{"system":"sec-edgar","filing":"0001477932-24-000042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224000042/form4.xml","form_type":"4"}},{"id":1687626,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2024-01-04T20:47:13.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81."}],"balance_after":471807,"source":{"system":"sec-edgar","filing":"0001477932-24-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793224000037/form4.xml","form_type":"4"}},{"id":1687629,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":17983,"kind":"person","name":"Ingargiola Luisa","position":1,"cik":"0001447277","reported_name":"Ingargiola Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2024-01-04T20:25:57.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81."}],"balance_after":48421,"source":{"system":"sec-edgar","filing":"0001477932-24-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447277/000147793224000035/form4.xml","form_type":"4"}},{"id":1767292,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":109241,"kind":"person","name":"Emry Kent","position":1,"cik":"0001589628","reported_name":"Emry Kent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-10-03T23:38:22.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Emry pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Emry. As compensation for his services, Mr. Emry shall be issued, upon the last day of each fiscal quarter, provided Mr. Emry is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.75."}],"balance_after":114065,"source":{"system":"sec-edgar","filing":"0001477932-23-007335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223007335/form4.xml","form_type":"4"}},{"id":1767291,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92183,"kind":"person","name":"GALLIGAN JOSEPH J","position":1,"cik":"0001198613","reported_name":"GALLIGAN JOSEPH J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-10-03T19:06:34.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.75."}],"balance_after":226119,"source":{"system":"sec-edgar","filing":"0001477932-23-007312","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223007312/primary_doc.xml","form_type":"4"}},{"id":1770324,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92266,"kind":"person","name":"Murthy Harsha","position":1,"cik":"0001962250","reported_name":"Murthy Harsha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-10-02T21:01:13.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Murthy pursuant to a Director Agreement, dated January 20, 2023, by and between BioCorRx Inc. and Mr. Murthy. As compensation for his services, Mr. Murthy shall be issued, upon the last day of each fiscal quarter, provided Mr. Murthy is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.75."}],"balance_after":7980,"source":{"system":"sec-edgar","filing":"0001477932-23-007298","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223007298/primary_doc.xml","form_type":"4"}},{"id":1770325,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":17983,"kind":"person","name":"Ingargiola Luisa","position":1,"cik":"0001447277","reported_name":"Ingargiola Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-10-02T20:56:37.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.75."}],"balance_after":42248,"source":{"system":"sec-edgar","filing":"0001477932-23-007297","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447277/000147793223007297/primary_doc.xml","form_type":"4"}},{"id":1770323,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-10-02T20:50:07.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.75."}],"balance_after":465634,"source":{"system":"sec-edgar","filing":"0001477932-23-007296","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223007296/primary_doc.xml","form_type":"4"}},{"id":1770322,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92265,"kind":"person","name":"Granier Brady James","position":1,"cik":"0001570636","reported_name":"Granier Brady James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2023-10-02T20:38:15.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":8574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 29, 2023, the issuer granted the reporting person an option that was 100% vested on issuance."}],"balance_after":8574,"derivative":{"exercise_price":1.75,"exercise_date":"2023-09-29","expiration_date":"2028-09-29","underlying":"Common Stock","underlying_shares":8574},"source":{"system":"sec-edgar","filing":"0001477932-23-007295","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223007295/primary_doc.xml","form_type":"4"}},{"id":1770321,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2023-10-02T20:30:13.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Felix pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.75."}],"balance_after":68656,"source":{"system":"sec-edgar","filing":"0001477932-23-007294","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223007294/primary_doc.xml","form_type":"4"}},{"id":1833764,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92183,"kind":"person","name":"GALLIGAN JOSEPH J","position":1,"cik":"0001198613","reported_name":"GALLIGAN JOSEPH J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-06T12:27:57.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.73."}],"balance_after":223261,"source":{"system":"sec-edgar","filing":"0001477932-23-005033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005033/form4.xml","form_type":"4"}},{"id":1833763,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92183,"kind":"person","name":"GALLIGAN JOSEPH J","position":1,"cik":"0001198613","reported_name":"GALLIGAN JOSEPH J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-06T12:27:57.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":2824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.77."}],"balance_after":220370,"source":{"system":"sec-edgar","filing":"0001477932-23-005033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005033/form4.xml","form_type":"4"}},{"id":1833762,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92183,"kind":"person","name":"GALLIGAN JOSEPH J","position":1,"cik":"0001198613","reported_name":"GALLIGAN JOSEPH J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-06T12:27:57.000Z","date":"2023-03-29","kind":"purchase","planned":false,"acquired":true,"shares":171296,"price":1.75,"value":299768.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were issued to The J and R Galligan Revocable Trust, managed by Mr. Joseph M. Galligan (the \"Galligan Trust\") pursuant to a subscription agreement by and between BioCorRx Inc. and the Galligan Trust dated March 29 2023, and paid for on March 30, 2023. The Reporting Person may be deemed to have investment power over the Galligan Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares were issued to The J and R Galligan Revocable Trust, managed by Mr. Joseph M. Galligan (the \"Galligan Trust\") pursuant to a subscription agreement by and between BioCorRx Inc. and the Galligan Trust dated March 29 2023, and paid for on March 30, 2023. The Reporting Person may be deemed to have investment power over the Galligan Trust."}],"balance_after":217546,"source":{"system":"sec-edgar","filing":"0001477932-23-005033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005033/form4.xml","form_type":"4"}},{"id":1833761,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92183,"kind":"person","name":"GALLIGAN JOSEPH J","position":1,"cik":"0001198613","reported_name":"GALLIGAN JOSEPH J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-06T12:27:57.000Z","date":"2022-12-30","kind":"grant","planned":false,"acquired":true,"shares":5319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.94."}],"balance_after":46250,"source":{"system":"sec-edgar","filing":"0001477932-23-005033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005033/form4.xml","form_type":"4"}},{"id":1833760,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92183,"kind":"person","name":"GALLIGAN JOSEPH J","position":1,"cik":"0001198613","reported_name":"GALLIGAN JOSEPH J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-06T12:27:57.000Z","date":"2022-09-30","kind":"grant","planned":false,"acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.04."}],"balance_after":40931,"source":{"system":"sec-edgar","filing":"0001477932-23-005033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005033/form4.xml","form_type":"4"}},{"id":1835984,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":109241,"kind":"person","name":"Emry Kent","position":1,"cik":"0001589628","reported_name":"Emry Kent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-05T21:05:28.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Emry pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Emry. As compensation for his services, Mr. Emry shall be issued, upon the last day of each fiscal quarter, provided Mr. Emry is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.73."}],"balance_after":111207,"source":{"system":"sec-edgar","filing":"0001477932-23-005021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005021/form4.xml","form_type":"4"}},{"id":1835983,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":109241,"kind":"person","name":"Emry Kent","position":1,"cik":"0001589628","reported_name":"Emry Kent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-05T21:05:28.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":2824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Emry pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Emry. As compensation for his services, Mr. Emry shall be issued, upon the last day of each fiscal quarter, provided Mr. Emry is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.77."}],"balance_after":108316,"source":{"system":"sec-edgar","filing":"0001477932-23-005021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005021/form4.xml","form_type":"4"}},{"id":1835982,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92266,"kind":"person","name":"Murthy Harsha","position":1,"cik":"0001962250","reported_name":"Murthy Harsha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-05T21:05:22.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Murthy pursuant to a Director Agreement, dated January 20, 2023, by and between BioCorRx Inc. and Mr. Murthy. As compensation for his services, Mr. Murthy shall be issued, upon the last day of each fiscal quarter, provided Mr. Murthy is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.73."}],"balance_after":5122,"source":{"system":"sec-edgar","filing":"0001477932-23-005020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005020/form4.xml","form_type":"4"}},{"id":1835981,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92265,"kind":"person","name":"Granier Brady James","position":1,"cik":"0001570636","reported_name":"Granier Brady James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2023-07-05T21:04:37.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":8673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2023, the issuer granted the reporting person an option that was 100% vested on issuance."}],"balance_after":8673,"derivative":{"exercise_price":1.73,"exercise_date":"2023-06-30","expiration_date":"2028-06-30","underlying":"Common Stock","underlying_shares":8673},"source":{"system":"sec-edgar","filing":"0001477932-23-005019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005019/form4.xml","form_type":"4"}},{"id":1835997,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":17983,"kind":"person","name":"Ingargiola Luisa","position":1,"cik":"0001447277","reported_name":"Ingargiola Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-05T21:04:07.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.73."}],"balance_after":39390,"source":{"system":"sec-edgar","filing":"0001477932-23-005018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447277/000147793223005018/form4.xml","form_type":"4"}},{"id":1835979,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-05T21:03:33.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.73."}],"balance_after":462776,"source":{"system":"sec-edgar","filing":"0001477932-23-005017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005017/form4.xml","form_type":"4"}},{"id":1835980,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2023-07-05T21:03:08.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Felix pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.73."}],"balance_after":65798,"source":{"system":"sec-edgar","filing":"0001477932-23-005016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223005016/form4.xml","form_type":"4"}},{"id":1924930,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-04-05T20:15:42.000Z","date":"2023-04-03","kind":"other","planned":false,"acquired":true,"shares":183606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the \"Company\") and Mr. Lucido dated April 3, 2023 (the \"Exchange Agreement\"). Pursuant to the Exchange Agreement, the Company agreed to issue 183,606 shares of its common stock, par value $0.001 per share, to Mr. Lucido and Mr. Lucido agreed to exchange, surrender and cancel that certain promissory note dated November 1, 2022 held by Mr. Lucido in the aggregate amount of $313,892, including interest."}],"balance_after":459885,"source":{"system":"sec-edgar","filing":"0001477932-23-002273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002273/form4.xml","form_type":"4"}},{"id":1924929,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-04-05T20:15:42.000Z","date":"2023-04-03","kind":"purchase","planned":false,"acquired":true,"shares":171296,"price":1.75,"value":299768.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017, managed by Mr. Louis C Lucido (the \"Lucido Trust\") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated March 29 2023, and paid for on April 3, 2023. The Reporting Person may be deemed to have investment power over the Lucido Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017, managed by Mr. Louis C Lucido (the \"Lucido Trust\") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated March 29 2023, and paid for on April 3, 2023. The Reporting Person may be deemed to have investment power over the Lucido Trust."}],"balance_after":276279,"source":{"system":"sec-edgar","filing":"0001477932-23-002273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002273/form4.xml","form_type":"4"}},{"id":1932250,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92266,"kind":"person","name":"Murthy Harsha","position":1,"cik":"0001962250","reported_name":"Murthy Harsha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-04-03T22:44:14.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":2231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Murthy pursuant to a Director Agreement, dated January 20, 2023, by and between BioCorRx Inc. and Mr. Murthy. As compensation for his services, Mr. Murthy shall be issued, upon the last day of each fiscal quarter, provided Mr. Murthy is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter; however, the number of shares issued to Mr. Murthy for such fiscal quarter is equivalent to a prorated amount of $3,948.72 to account for the number of days Mr. Murthy served as a member of the Board during such fiscal quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.77."}],"balance_after":2231,"source":{"system":"sec-edgar","filing":"0001477932-23-002231","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002231/form4.xml","form_type":"4"}},{"id":1932252,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":17983,"kind":"person","name":"Ingargiola Luisa","position":1,"cik":"0001447277","reported_name":"Ingargiola Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-04-03T22:31:44.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":2824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.77."}],"balance_after":36499,"source":{"system":"sec-edgar","filing":"0001477932-23-002229","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447277/000147793223002229/form4.xml","form_type":"4"}},{"id":1932249,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-04-03T22:29:37.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":2824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.77."}],"balance_after":104983,"source":{"system":"sec-edgar","filing":"0001477932-23-002226","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002226/form4.xml","form_type":"4"}},{"id":1932248,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92265,"kind":"person","name":"Granier Brady James","position":1,"cik":"0001570636","reported_name":"Granier Brady James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2023-04-03T22:29:16.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":8472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 31, 2023, the issuer granted the reporting person an option that was 100% vested on issuance."}],"balance_after":8472,"derivative":{"exercise_price":1.77,"exercise_date":"2023-03-31","expiration_date":"2028-03-31","underlying":"Common Stock","underlying_shares":8472},"source":{"system":"sec-edgar","filing":"0001477932-23-002225","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002225/form4.xml","form_type":"4"}},{"id":1932247,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2023-04-03T22:28:50.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":2824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Felix pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.77."}],"balance_after":62907,"source":{"system":"sec-edgar","filing":"0001477932-23-002224","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002224/form4.xml","form_type":"4"}},{"id":2040227,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-31T21:15:46.000Z","date":"2023-01-30","kind":"purchase","acquired":true,"shares":100,"price":1.37,"value":137.0,"ownership":{"direct":true},"balance_after":102159,"source":{"system":"sec-edgar","filing":"0001477932-23-000644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000644/form4.xml","form_type":"4"}},{"id":2040226,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-31T21:15:46.000Z","date":"2023-01-30","kind":"purchase","acquired":true,"shares":300,"price":1.39,"value":417.0,"ownership":{"direct":true},"balance_after":102059,"source":{"system":"sec-edgar","filing":"0001477932-23-000644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000644/form4.xml","form_type":"4"}},{"id":2043640,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-27T21:15:31.000Z","date":"2023-01-26","kind":"purchase","acquired":true,"shares":500,"price":1.293,"value":646.5,"ownership":{"direct":true},"balance_after":101759,"source":{"system":"sec-edgar","filing":"0001477932-23-000587","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000587/form4.xml","form_type":"4"}},{"id":2046359,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-25T19:32:34.000Z","date":"2023-01-24","kind":"purchase","acquired":true,"shares":200,"price":1.2,"value":240.0,"ownership":{"direct":true},"balance_after":101259,"source":{"system":"sec-edgar","filing":"0001477932-23-000530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000530/form4.xml","form_type":"4"}},{"id":2053686,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-17T21:15:17.000Z","date":"2023-01-13","kind":"purchase","acquired":true,"shares":2000,"price":1.15,"value":2300.0,"ownership":{"direct":true},"balance_after":101059,"source":{"system":"sec-edgar","filing":"0001477932-23-000335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000335/form4.xml","form_type":"4"}},{"id":2053685,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-17T21:15:17.000Z","date":"2023-01-13","kind":"purchase","acquired":true,"shares":2000,"price":1.1,"value":2200.0,"ownership":{"direct":true},"balance_after":99059,"source":{"system":"sec-edgar","filing":"0001477932-23-000335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000335/form4.xml","form_type":"4"}},{"id":2058700,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":17983,"kind":"person","name":"Ingargiola Luisa","position":1,"cik":"0001447277","reported_name":"Ingargiola Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-09T15:02:08.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":5319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.94."}],"balance_after":33675,"source":{"system":"sec-edgar","filing":"0001477932-23-000179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447277/000147793223000179/form4.xml","form_type":"4"}},{"id":2060287,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":109241,"kind":"person","name":"Emry Kent","position":1,"cik":"0001589628","reported_name":"Emry Kent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-06T12:09:09.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":5319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were issued to Mr. Emry pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Emry. As compensation for his services, Mr. Emry shall be issued, upon the last day of each fiscal quarter, provided Mr. Emry is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.94."}],"balance_after":105492,"source":{"system":"sec-edgar","filing":"0001477932-23-000145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000145/form4.xml","form_type":"4"}},{"id":2060286,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":109241,"kind":"person","name":"Emry Kent","position":1,"cik":"0001589628","reported_name":"Emry Kent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-06T12:09:09.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were issued to Mr. Emry pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Emry. As compensation for his services, Mr. Emry shall be issued, upon the last day of each fiscal quarter, provided Mr. Emry is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.04."}],"balance_after":100173,"source":{"system":"sec-edgar","filing":"0001477932-23-000145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000145/form4.xml","form_type":"4"}},{"id":2060285,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":109241,"kind":"person","name":"Emry Kent","position":1,"cik":"0001589628","reported_name":"Emry Kent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-06T12:09:09.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":2092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Emry pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Emry. As compensation for his services, Mr. Emry shall be issued, upon the last day of each fiscal quarter, provided Mr. Emry is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.39."}],"balance_after":97723,"source":{"system":"sec-edgar","filing":"0001477932-23-000145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000145/form4.xml","form_type":"4"}},{"id":2067074,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-04T21:16:00.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":2000,"price":1.1,"value":2200.0,"ownership":{"direct":true},"balance_after":97059,"source":{"system":"sec-edgar","filing":"0001477932-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000088/form4.xml","form_type":"4"}},{"id":2067073,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-04T21:16:00.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":5319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.94"}],"balance_after":95059,"source":{"system":"sec-edgar","filing":"0001477932-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000088/form4.xml","form_type":"4"}},{"id":2067072,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-04T21:16:00.000Z","date":"2022-12-30","kind":"purchase","acquired":true,"shares":115,"price":1.03,"value":118.45,"ownership":{"direct":true},"balance_after":89740,"source":{"system":"sec-edgar","filing":"0001477932-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000088/form4.xml","form_type":"4"}},{"id":2067071,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-04T21:16:00.000Z","date":"2022-12-30","kind":"purchase","acquired":true,"shares":200,"price":0.975,"value":195.0,"ownership":{"direct":true},"balance_after":89625,"source":{"system":"sec-edgar","filing":"0001477932-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000088/form4.xml","form_type":"4"}},{"id":2067070,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92265,"kind":"person","name":"Granier Brady James","position":1,"cik":"0001570636","reported_name":"Granier Brady James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2023-01-04T21:15:58.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":15957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 30, the issuer granted the reporting person an option that was 100% vested on issuance."}],"balance_after":15957,"derivative":{"exercise_price":0.94,"exercise_date":"2022-12-30","expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":15957},"source":{"system":"sec-edgar","filing":"0001477932-23-000089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000089/form4.xml","form_type":"4"}},{"id":2067069,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2023-01-04T21:15:28.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":5319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Felix pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.94."}],"balance_after":60083,"source":{"system":"sec-edgar","filing":"0001477932-23-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223000087/form4.xml","form_type":"4"}},{"id":2085029,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-12-15T12:29:18.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":2000,"price":0.8,"value":1600.0,"ownership":{"direct":true},"balance_after":89425,"source":{"system":"sec-edgar","filing":"0001477932-22-009312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222009312/form4.xml","form_type":"4"}},{"id":2085028,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-12-15T12:29:18.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":1000,"price":0.8,"value":800.0,"ownership":{"direct":true},"balance_after":87425,"source":{"system":"sec-edgar","filing":"0001477932-22-009312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222009312/form4.xml","form_type":"4"}},{"id":2085027,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-12-15T12:29:18.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":1000,"price":0.98,"value":980.0,"ownership":{"direct":true},"balance_after":86425,"source":{"system":"sec-edgar","filing":"0001477932-22-009312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222009312/form4.xml","form_type":"4"}},{"id":2085026,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-12-15T12:29:18.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":1000,"price":0.79,"value":790.0,"ownership":{"direct":true},"balance_after":85425,"source":{"system":"sec-edgar","filing":"0001477932-22-009312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222009312/form4.xml","form_type":"4"}},{"id":2139130,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-10-06","kind":"purchase","acquired":true,"shares":100,"price":1.73,"value":173.0,"ownership":{"direct":true},"balance_after":84425,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2139129,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-10-06","kind":"purchase","acquired":true,"shares":120,"price":1.9,"value":228.0,"ownership":{"direct":true},"balance_after":84325,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2139128,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-10-06","kind":"purchase","acquired":true,"shares":360,"price":1.9,"value":684.0,"ownership":{"direct":true},"balance_after":84205,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2139127,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":1000,"price":2.02,"value":2020.0,"ownership":{"direct":true},"balance_after":83845,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2139126,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-11T21:59:50.000Z","date":"2022-09-06","kind":"purchase","acquired":true,"shares":10,"price":2.1,"value":21.0,"ownership":{"direct":true},"balance_after":82845,"source":{"system":"sec-edgar","filing":"0001477932-22-007543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007543/form4.xml","form_type":"4"}},{"id":2142138,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-05T20:08:28.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.04."}],"balance_after":82835,"source":{"system":"sec-edgar","filing":"0001477932-22-007471","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007471/form4.xml","form_type":"4"}},{"id":2142137,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92265,"kind":"person","name":"Granier Brady James","position":1,"cik":"0001570636","reported_name":"Granier Brady James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2022-10-05T20:08:03.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":7350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 30, 2022, the issuer granted the reporting person an option that was 100% vested on issuance."}],"balance_after":7350,"derivative":{"exercise_price":2.04,"exercise_date":"2022-09-30","expiration_date":"2027-09-30","underlying":"Common Stock","underlying_shares":7350},"source":{"system":"sec-edgar","filing":"0001477932-22-007470","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007470/form4.xml","form_type":"4"}},{"id":2142143,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":17983,"kind":"person","name":"Ingargiola Luisa","position":1,"cik":"0001447277","reported_name":"Ingargiola Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-05T19:48:41.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.04."}],"balance_after":28356,"source":{"system":"sec-edgar","filing":"0001477932-22-007466","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447277/000147793222007466/form4.xml","form_type":"4"}},{"id":2142136,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":30754,"kind":"person","name":"Felix Lourdes","position":1,"cik":"0001569735","reported_name":"Felix Lourdes","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock, par value $0.001","published_at":"2022-10-05T19:48:16.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Ms. Felix pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.04."}],"balance_after":54764,"source":{"system":"sec-edgar","filing":"0001477932-22-007465","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222007465/form4.xml","form_type":"4"}},{"id":2169902,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-31T23:15:13.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":610,"price":2.12,"value":1293.2,"ownership":{"direct":true},"balance_after":80385,"source":{"system":"sec-edgar","filing":"0001477932-22-006572","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006572/form4.xml","form_type":"4"}},{"id":2169901,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-31T23:15:13.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":2268,"price":2.1,"value":4762.8,"ownership":{"direct":true},"balance_after":79775,"source":{"system":"sec-edgar","filing":"0001477932-22-006572","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006572/form4.xml","form_type":"4"}},{"id":2169900,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-31T23:15:13.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":1000,"price":2.12,"value":2120.0,"ownership":{"direct":true},"balance_after":77507,"source":{"system":"sec-edgar","filing":"0001477932-22-006572","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006572/form4.xml","form_type":"4"}},{"id":2171746,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-29T16:16:34.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":560,"price":2.12,"value":1187.2,"ownership":{"direct":true},"balance_after":76507,"source":{"system":"sec-edgar","filing":"0001477932-22-006484","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006484/form4.xml","form_type":"4"}},{"id":2171745,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-08-29T16:16:34.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":500,"price":2.18,"value":1090.0,"ownership":{"direct":true},"balance_after":75947,"source":{"system":"sec-edgar","filing":"0001477932-22-006484","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222006484/form4.xml","form_type":"4"}},{"id":2204533,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92265,"kind":"person","name":"Granier Brady James","position":1,"cik":"0001570636","reported_name":"Granier Brady James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2022-07-20T15:05:44.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":6276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2022, the issuer granted the reporting person an option that was 100% vested on issuance."}],"balance_after":6276,"derivative":{"exercise_price":2.39,"exercise_date":"2022-06-30","expiration_date":"2027-06-30","underlying":"Common Stock","underlying_shares":6276},"source":{"system":"sec-edgar","filing":"0001477932-22-005236","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222005236/form4.xml","form_type":"4"}},{"id":2209814,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":92183,"kind":"person","name":"GALLIGAN JOSEPH J","position":1,"cik":"0001198613","reported_name":"GALLIGAN JOSEPH J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-07-08T10:02:47.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":2092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.39."}],"balance_after":38481,"source":{"system":"sec-edgar","filing":"0001477932-22-004886","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222004886/form4.xml","form_type":"4"}},{"id":2210714,"issuer":{"id":8179,"kind":"organization","name":"BioCorRx Inc."},"owners":[{"id":83734,"kind":"person","name":"Lucido Louis C.","position":1,"cik":"0001539788","reported_name":"Lucido Louis C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2022-07-07T22:06:36.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":2092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.39."}],"balance_after":75447,"source":{"system":"sec-edgar","filing":"0001477932-22-004884","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222004884/form4.xml","form_type":"4"}}],"next_cursor":"2022-07-07T22:06:36.000000Z,2210714"}